Sign in to fuzzto save your conversations, follow your research and come back anytime.
Vanta Bioscience
SectorHealthcare
| Metric (₹ crore) | Q3 FY22 | Q4 FY22 | Q3 FY23 | Q4 FY23 |
|---|---|---|---|---|
| Sales | 0 | 4.31 | 2.82 | 0.63 |
| Expenses | 0 | 2.33 | 3.37 | 1.93 |
| EBITDA | 0 | 1.98 | -0.55 | -1.3 |
| Depreciation | 0 | 0.66 | 1.31 | 0.05 |
| EBIT | 0 | 1.32 | -1.86 | -1.35 |
| Interest | 0 | 1.2 | 2.48 | 0.92 |
| Profit Before Tax | 0 | 0.12 | -4.34 | -2.27 |
| Net Profit | 0 | 0.07 | -2.56 | -1.36 |
| EPS | 0 | 0.11 | -4.06 | 0 |
| Metric (₹ crore) | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.04 | 2.34 | 6.97 | 5.28 | -0.63 | 2.68 | -2.41 |
| Investing Cash Flow | -5.73 | -7.59 | -22.3 | -17.24 | -5.91 | -3.31 | -6.69 |
| Financing Cash Flow | 9.94 | 2.17 | 17.78 | 9.53 | 6.41 | 0.69 | 9.16 |
| Net Cash Flow | 3.17 | -3.08 | 2.45 | -2.43 | -0.13 | 0.06 | 0.06 |
| Metric (₹ crore) | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Equity / Shareholders' Funds | 23.23 | 24.46 | 26.23 | 29.35 | 18.92 | 12.97 | 3.78 |
| Total Liabilities | 15.77 | 24.12 | 43.4 | 52.06 | 65.78 | 72.42 | 82.1 |
| Total Assets | 39 | 48.57 | 69.63 | 81.4 | 84.71 | 85.4 | 85.88 |